Suspected interaction of oprelvekin (rhIL-11) with a long-acting opioid.
Moorehead
Paul
P
Mandel
Karen M
KM
Johnston
Donna L
DL
D000328:Adult; D000701:Analgesics, Opioid / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D004347:Drug Interactions; D005260:Female; D006801:Humans; D017370:Interleukin-11 / Q000009:adverse effects*; D007680:Kidney Neoplasms / Q000150:complications / Q000628:therapy; D009020:Morphine / Q000009:adverse effects*; D011994:Recombinant Proteins / Q000009:adverse effects; D013921:Thrombocytopenia / Q000209:etiology / Q000628:therapy; D009396:Wilms Tumor / Q000150:complications / Q000628:therapy
D000701:Analgesics, Opioid; D000970:Antineoplastic Agents; D017370:Interleukin-11; D011994:Recombinant Proteins; D009020:Morphine; C105308:oprelvekin